Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival.

Theiler A, Bärnthaler T, Platzer W, Richtig G, Peinhaupt M, Rittchen S, Kargl J, Ulven T, Marsh LM, Marsche G, Schuligoi R, Sturm EM, Heinemann A.

J Allergy Clin Immunol. 2019 Sep;144(3):764-776. doi: 10.1016/j.jaci.2019.05.002. Epub 2019 May 11.

2.

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.

Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton AM, Riddell SR.

Cancer Immunol Res. 2019 Jun;7(6):910-922. doi: 10.1158/2326-6066.CIR-18-0402. Epub 2019 May 1.

PMID:
31043415
3.

Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.

Lastwika KJ, Kargl J, Zhang Y, Zhu X, Lo E, Shelley D, Ladd JJ, Wu W, Kinahan P, Pipavath SNJ, Randolph TW, Shipley M, Lampe PD, Houghton AM.

Am J Respir Crit Care Med. 2019 May 15;199(10):1257-1266. doi: 10.1164/rccm.201804-0628OC.

PMID:
30422669
4.

Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.

Grill M, Hasenoehrl C, Kienzl M, Kargl J, Schicho R.

Histochem Cell Biol. 2019 Jan;151(1):5-20. doi: 10.1007/s00418-018-1719-0. Epub 2018 Sep 8.

5.

Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.

Veatch JR, Lee SM, Fitzgibbon M, Chow IT, Jesernig B, Schmitt T, Kong YY, Kargl J, Houghton AM, Thompson JA, McIntosh M, Kwok WW, Riddell SR.

J Clin Invest. 2018 Apr 2;128(4):1563-1568. doi: 10.1172/JCI98689. Epub 2018 Mar 12.

6.

Macrophage-Dependent Cytoplasmic Transfer during Melanoma Invasion In Vivo.

Roh-Johnson M, Shah AN, Stonick JA, Poudel KR, Kargl J, Yang GH, di Martino J, Hernandez RE, Gast CE, Zarour LR, Antoku S, Houghton AM, Bravo-Cordero JJ, Wong MH, Condeelis J, Moens CB.

Dev Cell. 2017 Dec 4;43(5):549-562.e6. doi: 10.1016/j.devcel.2017.11.003.

7.

Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.

Mark NM, Kargl J, Busch SE, Yang GHY, Metz HE, Zhang H, Hubbard JJ, Pipavath SNJ, Madtes DK, Houghton AM.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):325-336. doi: 10.1164/rccm.201704-0795OC.

8.

Mutant IDH1 regulates the tumor-associated immune system in gliomas.

Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J, Hockenbery D, Houghton AM, Holland EC.

Genes Dev. 2017 Apr 15;31(8):774-786. doi: 10.1101/gad.294991.116. Epub 2017 May 2.

9.

Neutrophils dominate the immune cell composition in non-small cell lung cancer.

Kargl J, Busch SE, Yang GH, Kim KH, Hanke ML, Metz HE, Hubbard JJ, Lee SM, Madtes DK, McIntosh MW, Houghton AM.

Nat Commun. 2017 Feb 1;8:14381. doi: 10.1038/ncomms14381.

10.

Lung Cancer Subtypes Generate Unique Immune Responses.

Busch SE, Hanke ML, Kargl J, Metz HE, MacPherson D, Houghton AM.

J Immunol. 2016 Dec 1;197(11):4493-4503. Epub 2016 Oct 31.

11.

Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma.

Metz HE, Kargl J, Busch SE, Kim KH, Kurland BF, Abberbock SR, Randolph-Habecker J, Knoblaugh SE, Kolls JK, White MF, Houghton AM.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8795-800. doi: 10.1073/pnas.1601989113. Epub 2016 Jul 20.

12.

GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.

Kargl J, Andersen L, Hasenöhrl C, Feuersinger D, Stančić A, Fauland A, Magnes C, El-Heliebi A, Lax S, Uranitsch S, Haybaeck J, Heinemann A, Schicho R.

Br J Pharmacol. 2016 Jan;173(1):142-54. doi: 10.1111/bph.13345. Epub 2015 Nov 25.

13.

Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis.

Gregory AD, Kliment CR, Metz HE, Kim KH, Kargl J, Agostini BA, Crum LT, Oczypok EA, Oury TA, Houghton AM.

J Leukoc Biol. 2015 Aug;98(2):143-52. doi: 10.1189/jlb.3HI1014-493R. Epub 2015 Mar 5.

14.

Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.

Balenga NA, Martínez-Pinilla E, Kargl J, Schröder R, Peinhaupt M, Platzer W, Bálint Z, Zamarbide M, Dopeso-Reyes IG, Ricobaraza A, Pérez-Ortiz JM, Kostenis E, Waldhoer M, Heinemann A, Franco R.

Br J Pharmacol. 2014 Dec;171(23):5387-406. doi: 10.1111/bph.12850. Epub 2014 Sep 5.

15.

Reasons for dissatisfaction ten years after TVT procedure.

Aigmueller T, Bjelic-Radisic V, Kargl J, Hinterholzer S, Laky R, Trutnovsky G, Kolovetsiou-Kreiner V, Tamussino K.

Int Urogynecol J. 2014 Feb;25(2):213-7. doi: 10.1007/s00192-013-2213-9. Epub 2013 Sep 13.

PMID:
24030215
16.

A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.

Kargl J, Brown AJ, Andersen L, Dorn G, Schicho R, Waldhoer M, Heinemann A.

J Pharmacol Exp Ther. 2013 Jul;346(1):54-66. doi: 10.1124/jpet.113.204180. Epub 2013 May 2.

PMID:
23639801
17.

The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.

Kargl J, Balenga N, Parzmair GP, Brown AJ, Heinemann A, Waldhoer M.

J Biol Chem. 2012 Dec 28;287(53):44234-48. doi: 10.1074/jbc.M112.364109. Epub 2012 Nov 16.

18.

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.

Kargl J, Haybaeck J, Stančić A, Andersen L, Marsche G, Heinemann A, Schicho R.

J Mol Med (Berl). 2013 Apr;91(4):449-58. doi: 10.1007/s00109-012-0957-1. Epub 2012 Sep 11.

19.

Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M.

Mol Endocrinol. 2011 Nov;25(11):1835-48. doi: 10.1210/me.2011-1197. Epub 2011 Sep 29. Review.

20.

Ten-year follow-up after the tension-free vaginal tape procedure.

Aigmueller T, Trutnovsky G, Tamussino K, Kargl J, Wittmann A, Surtov M, Kern P, Frudinger A, Riss P, Bjelic-Radisic V.

Am J Obstet Gynecol. 2011 Nov;205(5):496.e1-5. doi: 10.1016/j.ajog.2011.07.010. Epub 2011 Jul 20.

PMID:
21944223
21.

Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55.

Balenga NA, Henstridge CM, Kargl J, Waldhoer M.

Adv Pharmacol. 2011;62:251-77. doi: 10.1016/B978-0-12-385952-5.00004-X. Review.

PMID:
21907912
22.

The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.

Kargl J, Balenga NA, Platzer W, Martini L, Whistler JL, Waldhoer M.

Br J Pharmacol. 2012 Apr;165(8):2611-9. doi: 10.1111/j.1476-5381.2011.01562.x.

23.

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.

Balenga NA, Aflaki E, Kargl J, Platzer W, Schröder R, Blättermann S, Kostenis E, Brown AJ, Heinemann A, Waldhoer M.

Cell Res. 2011 Oct;21(10):1452-69. doi: 10.1038/cr.2011.60. Epub 2011 Apr 5. Erratum in: Cell Res. 2011 Nov;21(11):1641.

24.

Quality of life and urinary incontinence in women.

Riss P, Kargl J.

Maturitas. 2011 Feb;68(2):137-42. doi: 10.1016/j.maturitas.2010.11.006. Epub 2010 Dec 30. Review.

PMID:
21195563
25.

G protein-coupled receptor-associated sorting protein 1 regulates the postendocytic sorting of seven-transmembrane-spanning G protein-coupled receptors.

Moser E, Kargl J, Whistler JL, Waldhoer M, Tschische P.

Pharmacology. 2010;86(1):22-9. doi: 10.1159/000314161. Epub 2010 Jun 26. Review.

26.

GPR55 ligands promote receptor coupling to multiple signalling pathways.

Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, Waldhoer M, Irving AJ.

Br J Pharmacol. 2010 Jun;160(3):604-14. doi: 10.1111/j.1476-5381.2009.00625.x. Epub 2010 Feb 5.

Supplemental Content

Support Center